Patient advocacy groups like the Children’s Tumor Foundation play many roles from funding medical research, providing support, resources and a community ‘voice’ for patients. At the Biotechnology Industry Organization 2009 Annual Conference, a forum for pharmaceutical and biotechnology companies, and more recently for patient advocacy groups to interact and partner with these entities, CTF’s Chief Scientific Officer Dr. Kim Hunter-Schaedle featured in a short video highlighting the role of patient advocacy groups. View this now at
http://biotech-now.org/biodigest-patient-advocacy-011790.html
